{
    "2021-12-19": [
        [
            {
                "time": "",
                "original_text": "安信证券：给予爱尔眼科增持评级，目标价位50.4元",
                "features": {
                    "keywords": [
                        "安信证券",
                        "爱尔眼科",
                        "增持评级",
                        "目标价位"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "爱尔眼科布局海南博鳌乐城先行区，打造国际临床研究基地",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "海南博鳌乐城",
                        "先行区",
                        "国际临床研究基地"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}